Bill
Bill > HB263
DE HB263
DE HB263An Act To Amend Title 18 And Title 29 Of The Delaware Code Relating To Cost Sharing In Prescription Insulin Drugs.
summary
Introduced
01/09/2020
01/09/2020
In Committee
02/28/2020
02/28/2020
Crossed Over
01/30/2020
01/30/2020
Passed
06/16/2020
06/16/2020
Dead
Signed/Enacted/Adopted
07/16/2020
07/16/2020
Introduced Session
150th General Assembly
Bill Summary
This Act requires that individual, group, and State employee insurance plans cap the amount an individual must pay for insulin prescriptions at $100 a month and must include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier.
AI Summary
This bill requires that individual, group, and state employee insurance plans in Delaware cap the amount an individual must pay for prescription insulin drugs at $100 per month and include at least one formulation of each type of insulin (rapid-acting, short-acting, intermediate-acting, and long-acting) on the lowest tier of the drug formulary developed by the carrier. The bill applies to all policies, contracts, or certificates issued, renewed, modified, or reissued after December 31, 2020.
Committee Categories
Health and Social Services
Sponsors (31)
Andria Bennett (D)*,
David Bentz (D)*,
Sherry Dorsey Walker (D)*,
Melissa Minor-Brown (D)*,
Paul Baumbach (D),
Stephanie Bolden (D),
Gerald Brady (D),
Darius Brown (D),
Nnamdi Chukwuocha (D),
Frank Cooke (D),
Krista Griffith (D),
Debra Heffernan (D),
Earl Jaques (D),
Kendra Johnson (D),
John Kowalko (D),
Tizzy Lockman (D),
Valerie Longhurst (D),
Ernesto López (R),
Sean Lynn (D),
Harris McDowell (D),
John Mitchell (D),
Ed Osienski (D),
Trey Paradee (D),
Raymond Seigfried (D),
Mike Smith (R),
Dave Sokola (D),
Laura Sturgeon (D),
Bryan Townsend (D),
John Viola (D),
Jack Walsh (D),
Kim Williams (D),
Last Action
Signed by Governor (on 07/16/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...